Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the pricing of its concurrent public offerings of (i) $625,000,000 aggregate principal amount of 0.00% convertible senior notes due 2032 ...
BSE Sensex and NSE Nifty opened marginally lowered on Thursday following weak global cues and continued FII selling.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback